FDA Investigator Camille D Brown

Camille D Brown has inspections in 12 countries as of 04 Nov 2022. Camille D Brown has collaborated with a combinined 1877 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
04 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
United States of America, India, Spain, Poland, France, Hungary, Jordan, Italy, Canada, Australia, South Africa
Adam C Hipko, Adrian Rodriguez, Alanna Lmussawwir Bias, Amanda J White, Andrace Lde Yampert, Andrea A Branche, Angela Mock, Arie R Dyk, Bing Lin, Brackens Harris, Brandi E Williams, Charles D Brown, Christopher D Rush, Christopher J Smith, Connie L Hannon Rabel, Corrine M Carter, Crystal S Harris Smith, Cynthia A Harris, MD, RN, Dallas E Gilbreath Jr, Daniel S Fam, Danny D Horner, Darla J Christopher, Deborah A Greco, Denise Connelly, Denise L Burosh, Elisa M Fleming, Ellen J Tave, Elmina E Akwo, Elvia J Cervantes, Fernando C Martinez, Gajendiran Mahadevan, PhD, Gatica, Gene R Gunn, Glasgow, Grant, Iris C Macinnes, Jacob W Reynolds, James H Robinson, Jamie M Bumpas, Jane M Broussard, Janet B Abt, Janete F Guardia, Janice M Hickok, Jeffrey R Wooley, Jennifer C Adams, Jennifer D Young, Jennifer Owens Dowdy, Joanne M Schlossin, Joel D Martinez, Johann M Fitch, Johnson, Jonathan A Womack, Joy L Ramsey, Keegan B Mixon, Kelly D Sheppard, Kelly J Pegg, Kenitra D Hewitt, Kip J Hanks, Kirsten S Tharp, Lauren E Skokan, Leighton K Ngai, Lisa R Jennings, Liza L Quiles, Lloyd D Payne, Lorie S Hannappel, Lourdes R Genera, Maira P Brading, Makini Cobourne Duval, PhD, Marc R Dickens, Marilyn S Babu, Mario Seminara, Mathew T Thomas, MD, Monique Rac Lester, Monique S Frazier, Myra K Casey, Nancy A Bellamy, Nicola M Fenty Stewart, Patrice S Hall, Patrick D Stone, MS, Paul E Frazier, Pauline N Logan, Payne, Peter R Lenahan, Phillip D Waldron, Rebecca C O Bryan, Rebecca T Davis, Rene R Ramirez, Rhonda L Dash, Rian L Pope, Robert T Lorenz, Ronald L Koller, Ronda R Loyd Jones, Ruben C Ayala, PharmD, Sam H Haidar, PhD, Scott B Laufenberg, Scott T Ballard, Shannon A Lowe, Sherri J Jackson, Shirley H Isbill, State Agency, Tamera H Hunt, Tawny L Colling, Toby Vern H Hill, Travis M Beard, Travis S Brown, Tricia S Martinez, William S Vitale, Yaw O Osei, Yoonyc, Young M Yoon

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more